Related references
Note: Only part of the references are listed.Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China Prevalence, Risk Factors, and Outcome
Li Zhang et al.
CIRCULATION (2020)
The case of complement activation in COVID-19 multiorgan impact
Marina Noris et al.
KIDNEY INTERNATIONAL (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Complement C5 inhibition in patients with COVID-19-a promising target?
Regis Peffault de Latour et al.
HAEMATOLOGICA (2020)
The complement system in COVID-19: friend and foe?
Anuja Java et al.
JCI INSIGHT (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation
Fadi Fakhouri et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Pandemic H1N1 influenza A infection and (atypical) HUS-more than just another trigger?
Upton Allen et al.
PEDIATRIC NEPHROLOGY (2011)